Hakutulokset - Spring, Laura

Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current stat... Tekijä Spring, Laura, Bardia, Aditya, Modi, Shanu

Hae kokoteksti Hae kokoteksti

Mammography Decision-Making: Trends and Predictors of Provider Communication in the Health Information National Trends Survey 2011–2014 Tekijä Spring, Laura M., Marshall, Megan R., Warner, Erica T.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations Tekijä Spring, Laura M., Zangardi, Mark L., Moy, Beverly, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions Tekijä Spring, Laura M., Wander, Seth A., Zangardi, Mark, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer Tekijä Brett, Jamie O., Spring, Laura M., Bardia, Aditya, Wander, Seth A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Stevens-Johnson syndrome–like eruption from palbociclib in a patient with metastatic breast cancer Tekijä Karagounis, Theodora, Vallurupalli, Mounica, Nathan, Neera, Nazarian, Rosalynn, Vedak, Priyanka, Spring, Laura, Chen, Steven T.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities Tekijä Spring, Laura M., Nakajima, Erika, Hutchinson, Jennifer, Viscosi, Elene, Blouin, Gayle, Weekes, Colin, Rugo, Hope, Moy, Beverly, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis Tekijä Spring, Laura M., Gupta, Arjun, Reynolds, Kerry L., Gadd, Michele A., Ellisen, Leif W., Isakoff, Steven J., Moy, Beverly, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series Tekijä Gazourian, Lee, Spring, Laura, Meserve, Emily, Hwang, David, Diaz, Alejandro A., Ash, Samuel Y., Ho, Vincent T., Sholl, Lynette M., Washko, George R.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic Tekijä Spring, Laura M., Specht, Michelle C., Jimenez, Rachel B., Isakoff, Steven J., Wang, Gary X., Ly, Amy, Shin, Jennifer A., Bardia, Aditya, Moy, Beverly

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry Tekijä Smith, Barbara L., Nguyen, Anvy, Korotkin, Jenna E., Kelly, Bridget N., Specht, Michelle C., Spring, Laura M., Moy, Beverly, Isakoff, Steven J., Gadd, Michele A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer Tekijä Bychkovsky, Brittany L., Guo, Hao, Sutton, Jazmine, Spring, Laura, Faig, Jennifer, Dagogo-Jack, Ibiayi, Battelli, Chiara, Houlihan, Mary Jane, Yeh, Tsai-Chu, Come, Steven E., Lin, Nancy U.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis Tekijä Spring, Laura M., Fell, Geoffrey, Arfe, Andrea, Sharma, Chandni, Greenup, Rachel, Reynolds, Kerry L., Smith, Barbara L., Alexander, Brian, Moy, Beverly, Isakoff, Steven J., Parmigiani, Giovanni, Trippa, Lorenzo, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion Tekijä Mortensen, Lindsey, Ordulu, Zehra, Dagogo‐Jack, Ibiayi, Bossuyt, Veerle, Winters, Loren, Taghian, Alphonse, Smith, Barbara L., Ellisen, Leif W., Kiedrowski, Lesli A., Lennerz, Jochen K., Bardia, Aditya, Spring, Laura M.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer Tekijä Spring, Laura M., Clark, Shealagh L., Li, Tianyu, Goel, Shom, Tayob, Nabihah, Viscosi, Elene, Abraham, Elizabeth, Juric, Dejan, Isakoff, Steven J., Mayer, Erica, Moy, Beverly, Supko, Jeffrey G., Tolaney, Sara M., Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effectiveness and tolerability of neoadjuvant pertuzumab containing regimens for HER2-positive localized breast cancer. Tekijä Spring, Laura, Niemierko, Andrzej, Haddad, Stephanie, Yuen, Megan, Comander, Amy, Reynolds, Kerry, Shin, Jennifer, Bahn, Atul, Brachtel, Elena, Specht, Michelle, Smith, Barbara L., Taghian, Alphonse, Jimenez, Rachel, Peppercorn, Jeffrey, Isakoff, Steven J., Moy, Beverly, Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

FGFR1 gene amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor positive (HR+) breast cancer Tekijä Drago, Josh, Formisano, Luigi, Juric, Dejan, Niemierko, Andrzej, Servetto, Alberto, Wander, Seth, Spring, Laura, Vidula, Neelima, Peppercorn, Jeffrey, Younger, Jerry, Malvarosa, Giuliana, Yuen, Megan, Sgroi, Dennis, Isakoff, Steven J., Moy, Beverly, Ellisen, Leif W., Iafrate, John, Arteaga, Carlos L., Bardia, Aditya

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses Tekijä Koh, Siang-Boon, Dontchos, Brian N., Bossuyt, Veerle, Edmonds, Christine, Cristea, Simona, Melkonjan, Nsan, Mortensen, Lindsey, Ma, Annie, Beyerlin, Kassidy, Denault, Elyssa, Niehoff, Elizabeth, Hirz, Taghreed, Sykes, David B., Michor, Franziska, Specht, Michelle, Lehman, Constance, Ellisen, Leif W., Spring, Laura M.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A digital RNA signature of Circulating Tumor Cells predicting early therapeutic response in localized and metastatic breast cancer Tekijä Kwan, Tanya T., Bardia, Aditya, Spring, Laura M., Giobbie-Hurder, Anita, Kalinich, Mark, Dubash, Taronish, Sundaresan, Tilak, Hong, Xin, LiCausi, Joseph A., Ho, Uyen, Silva, Erin J., Wittner, Ben S., Sequist, Lecia V., Kapur, Ravi, Miyamoto, David T., Toner, Mehmet, Haber, Daniel A., Maheswaran, Shyamala

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy Tekijä Griffiths, Jason I., Chen, Jinfeng, Cosgrove, Patrick A., O’Dea, Anne, Sharma, Priyanka, Ma, Cynthia, Trivedi, Meghna, Kalinsky, Kevin, Wisinski, Kari B., O’Regan, Ruth, Makhoul, Issam, Spring, Laura M., Bardia, Aditya, Adler, Frederick R., Cohen, Adam L., Chang, Jeffrey T., Khan, Qamar J., Bild, Andrea H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti